0001683168-23-006511.txt : 20230918 0001683168-23-006511.hdr.sgml : 20230918 20230918090008 ACCESSION NUMBER: 0001683168-23-006511 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20230915 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20230918 DATE AS OF CHANGE: 20230918 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AETHLON MEDICAL INC CENTRAL INDEX KEY: 0000882291 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 133632859 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37487 FILM NUMBER: 231260232 BUSINESS ADDRESS: STREET 1: 11555 SORRENTO VALLEY ROAD, SUITE 203 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-459-7800 MAIL ADDRESS: STREET 1: 11555 SORRENTO VALLEY ROAD, SUITE 203 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: BISHOP EQUITIES INC DATE OF NAME CHANGE: 19930602 8-K 1 aethlon_8k.htm FORM 8-K
0000882291 false 0000882291 2023-09-15 2023-09-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 15, 2023

 

AETHLON MEDICAL, INC.

(Exact name of Registrant as Specified in Its Charter)

 

Nevada 001-37487 13-3632859

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(IRS Employer Identification No.)

 

   

11555 Sorrento Valley Road, Suite 203

San Diego, California

 92121
(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (619) 941-0360

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.001 par value per share

 AEMD The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

   

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders

 

We held our 2023 Annual Meeting of Stockholders on September 15, 2023 (the “Annual Meeting”), in which our stockholders approved Proposals 1-3 listed below. Based on the report of the Inspector of Elections for the Annual Meeting, 9,012,954 shares out of 24,835,321 shares outstanding and entitled to vote, or approximately 36.29%, were present at the meeting virtually or by proxy. The final results for the votes regarding each proposal are set forth in the following tables. Each of these proposals is described in detail in the proxy statement.

 

  1. Elect six members of our Board of Directors (the “Board”). All of the nominees were elected.

 

Name Votes For Votes Against Abstentions
Edward G. Broenniman 4,746,036 435,339 120,979
Guy F. Cipriani 4,859,449 322,920 119,985
Charles J. Fisher, Jr., MD 4,857,852 328,276 116,226
Nicolas Gikakis 4,859,443 321,710 121,201
Angela Rossetti 4,855,281 327,149 119,924
Chetan S. Shah, MD 4,870,838 316,233 115,283

 

  2. Ratify the appointment of Baker Tilly US, LLP as our independent registered public accounting firm for our fiscal year ending March 31, 2024. The resolution was approved.

 

Votes For Votes Against Abstentions
8,177,582 562,051 273,321

 

  3. Approve, pursuant to Nevada Revised Statutes (“NRS”) 78.2055, a reverse stock split of our common stock at a ratio in the range of 1-for-8 to 1-for-12, with such ratio to be determined in the discretion of the Board and with such reverse stock split to be effected at such time and date as determined by the Board in its sole discretion (but in no event later than October 5, 2023). The resolution was approved.

 

Votes For Votes Against Abstentions
6,781,311 2,180,424 51,219

 

 

 

 

 

 

 2 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: September 18, 2023

 

Aethlon Medical, Inc.

     
     
  By:   /s/ James B. Frakes
 

Name:

 

  

James B. Frakes

Chief Financial Officer

 

 

 

 

 

 

 

 

 

 

 

 3 

 EX-101.SCH 2 aemd-20230915.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 aemd-20230915_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 4 aemd-20230915_pre.xml XBRL PRESENTATION FILE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Sep. 15, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Sep. 15, 2023
Entity File Number 001-37487
Entity Registrant Name AETHLON MEDICAL, INC.
Entity Central Index Key 0000882291
Entity Tax Identification Number 13-3632859
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 11555 Sorrento Valley Road
Entity Address, Address Line Two Suite 203
Entity Address, City or Town San Diego
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92121
City Area Code 619
Local Phone Number 941-0360
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.001 par value per share
Trading Symbol AEMD
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 6 aethlon_8k_htm.xml IDEA: XBRL DOCUMENT 0000882291 2023-09-15 2023-09-15 iso4217:USD shares iso4217:USD shares 0000882291 false 8-K 2023-09-15 AETHLON MEDICAL, INC. NV 001-37487 13-3632859 11555 Sorrento Valley Road Suite 203 San Diego CA 92121 619 941-0360 false false false false Common Stock, $0.001 par value per share AEMD NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://aethlonmedical.com/role/Cover Cover Cover 1 false false All Reports Book All Reports aemd-20230915.xsd aemd-20230915_lab.xml aemd-20230915_pre.xml aethlon_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "aethlon_8k.htm": { "nsprefix": "AEMD", "nsuri": "http://aethlonmedical.com/20230915", "dts": { "schema": { "local": [ "aemd-20230915.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "aemd-20230915_lab.xml" ] }, "presentationLink": { "local": [ "aemd-20230915_pre.xml" ] }, "inline": { "local": [ "aethlon_8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://aethlonmedical.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2023-09-15", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "aethlon_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-15", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "aethlon_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://aethlonmedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 13 0001683168-23-006511-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001683168-23-006511-xbrl.zip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end